Transcranial Ultrasound in Clinical SONothrombolysis

Summary

This is a randomized, placebo controlled, parallel group dose escalation trial to evaluate the safety, tolerability, and activity of four sequential dose tiers of MRX-801 and ultrasound as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.

Timeline

Start

2006-12

Primary completion

—

Completion

2008-03

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications